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Helper/inducer T lymphocytes recognize protein antigens in association with
class II MHC (Ia) determinants on APC. Proliferative responses of such T cells
to antigen + la, antireceptor antibodies, alloantigens, or lectins also require
"accessory" signals that, for different T cell populations, have been shown to be
provided by a secreted or membrane-associated form ofthe monokine, IL-1 (I-
4), or by undefined stimuli provided by accessory cells which can often be
replaced by phorbol esters (5-8). Little is known abouthowsuch accessory signals
permit or enhance Tcell proliferation. In fact, detailed analysis ofthis question
has been difficult because of variability among different T cell clones and bulk
populations in their use of different accessory stimuli. Thus, it is unclear why
some Tcells are IL-1-responsive and others are not.
Recent work from several laboratories (9-11) has shown that murine
helper/inducer T lymphocytes are composed of at least two nonoverlapping
subsets that can be distinguished on the basis of their patterns of lymphokine
secretion. One subset, provisionally termed Thl, produces IL-2 and IFN-y in
response to antigen receptor-mediated or lectin-mediated stimulation, and ex-
clusively uses IL-2 as its autocrine growth factor. The other Tcell subset, called
Th2, secretes B cell stimulatory factor I (BSF-I)t/IL-4 and uses IL-4 as its
autocrine growth factor but does not secrete IL-2.
At present these subsets cannot be distinguishedphenotypically. It isreasonable
to postulate that Th1 cells are important in cell-mediated immunity (delayed
hypersensitivity, cytotoxic T cell generation), whereas the Th2 subset may play
a major role in the induction of antibody responses, but such functional differ-
ences have not been definitively established and are the subject of active inves-
tigation.
In the course of studies analyzing the functions of various T cell subsets, we
have examined the proliferative responses ofcloned lines representing ThI and
Th2 cells to exogenous lymphokines, and the roles of accessory factors in Tcell
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proliferation. Our results demonstrate striking differences between such clones
in responses to exogenous IL-2 and IL-4, and in their dependence on IL-1 as an
accessory signal. The implications of these results for our current understanding
of T cell activation and the regulation of cellular immunity are discussed.
Materials and Methods
T Cell Clones.
￿
The following T cell clones, whose properties are described in Results,
were used for this study: DIO.G4, obtained from Dr. C. Janeway, Yale University School
of Medicine, New Haven, CT (1); CDC25 and CDC35, from Dr. D. Parker, University
of Massachusetts Medical School, Worcester, MA (12); B8 and GI 1, from Dr. W. H.
Boom, Harvard School of Public Health, Boston, MA (13); and DI A , D1 .5 and D1.6,
generated in our laboratory from lymph nodes of BALB/c mice immunized with rabbit
IgG in CFA. These cells were subjected to multiple cycles of resti
cloned by limiting dilution (14). All clones were maintained by weekly stimulation wi
irradiated splenocytes and antigen. Splenocytes were isolated from AKR/J mice (for
D10.G4), BALB/cJ (for CDC35, DIA, DL5, and D1 .6), C57BL/6 (for B8 and G11), and
(C3H X DBA/2)F, (for CDC25). Mice, 8-12 wk old, were purchased from The Jackson
Laboratory, Bar Harbor, ME, and maintained in accordance with guidelines of the
Committee on Animals of the Harvard Medical School and those prepared by the
Committee on Care and Use ofLaboratory Animals ofthe Institute ofLaboratory Animal
Resources, National Research Council (DREW Publication No. (NIH) 78-23). Clones
were maintained by stimulating 105 viable T cells with 5 X 106 1,500 rad irradiated
splenocytes and 100 Ag/ml of antigen in 2 ml of RPMI 1640 supplemented with 2 MM L-
glutamine, penicillin, streptomycin, nonessential amino acids, 5 X 10-5 M 2-ME and 10%
heat-inactivated FCS. Cultures also contained 5% vol/vol Con A-induced supernatant of
rat spleen cells (RCS), from which the Con A was removed by absorption with Sephadex
G10. Residual Con A was neutralized with an excess of a-methyl mannoside. Cells were
incubated in 16-mm wells at 37°C in 5% C02. For some experiments, DIO.G4 cells were
restimulated without RCS for 7-8 d, at which time RCS was added to a final concentration
of 5% vol/vol. The specificity and Ia restrictions of clones were defined by blocking
proliferative responses to antigen plus stimulator cells with mAbs specific for I-A and I-E.
Cytokines, Antibodies, and Chemicals.
￿
Human and murine rIL2 were purchased from
Genzyme Corp., Boston, MA, and used according to units as defined by the supplier.
Recombinant murine BSF-1/IL-4 (expressed in yeast) was generouslyprovided by Dr. S.
Gillis, Immunex Corp., Seattle, WA (15). The activity ofthis preparation was determined
at Immunex Corp.; 1 U is equivalent to 0.1-0.2 U we have used in earlier studies using
T cell-derived HPLC- and affinity-purified BSF-1 (5, 10, 16). For some experiments, we
also used the unfractionated supernatant ofDIO.G4 cells stimulated for 18 h with 2 ug/ml
Con A as a crude source of BSF-I/IL-4. Residual Con A was neutralized with 20 mg/ml
a-methyl mannoside. By antibody inhibition (see below), the only T cell-stimulating
activity in this supernatant is BSF-1/IL-4, i.e., no detectable IL-2 is present. Human rIL-
1# was purchased from Cistron Technologies, Pine Brook, NJ; units are defined by the
supplier on the basis of thymocyte proliferation assays. Con A and the antigens, conalbu-
min and rabbit IgG, were purchased from Sigma Chemical Co., St. Louis, MO. The
neutralizing mAb for BSF-1/IL-4, I IB11, has been described previously (17) and was
used as hybridoma culture supernatant at a final dilution of 1 :40. Anti-IL-2 antibody,
S4B6, was a gift of Dr. T. Mosmann, DNAX Corp., Palo Alto, CA, and was used at a
1 :20 dilution of an (NH4)2SO4-precipitated 20X concentrate of hybridoma supernatant.
Anti-IL-2-R antibodies used were 7D4 (18) and PC61 (19); for antibody blocking, we
used hybridoma supernatants concentrated 20 times by (NH4)2SO4 precipitation, mixed
in equal proportions, and added to cultures at a final dilution of 1 :100 or 1 :200, as
described previously (10). Other mAbs used as hybridoma supernatants for immunofluo-
rescence, were anti-L3T4 (GKI.5) and rat anti-mouse Lyt-2 (No. TIB105; American
Type Culture Collection, Rockville, MD).
Cultures and Assays.
￿
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were measured using cells harvested 8-10 d after stimulation with antigen. Viable cells
were purified by centrifugation over Ficoll-Isopaque, and 2 X 104 cells were cultured in
duplicate with various stimuli in 0.2 ml of RPMI 1640, supplemented as described above,
in flat-bottomed microculture plates. Cultures were incubated for 2-5 d at 37°C in 5%
C02, pulsed for the final 6-8 h with I uCi [5H]thymidine (Amersham Corp., Arlington
Heights, IL) per well and harvested in a PHD cell harvester (Cambridge Technology,
Inc., Cambridge, MA). Radioactivity incorporated into DNA was measured by liquid
scintillation counting, and data were expressed as mean cpm [5H]thymidine incorporation
per culture.
For assays of lymphokine secretion by T cells, 2 X 104 viable cells were cultured in 0.2
ml with 2 ug/ml ofCon A or 5 X 105 1,500rad irradiated splenocytes from the appropriate
strain and 50 or 100 jug/ml antigen. Supernatants were collected on day 1 or 2, and
assayed at 50% vol/vol for stimulation of HT2 cells in the presence and absence of anti-
BSF-1/IL-4 or anti-IL-2-R antibodies, as described previously (10).
Measurement of BSF-1/IL-4-R Expression.
￿
Affinity-purified BSF-1/IL-4 was iodinated
as previously described. Biologic activity of '25I-IL-4 was comparable to that of noniodi-
nated IL-4 as measured in a T cell costimulation assay (5). BSF-1/IL-4-R expression was
measured as described (20). Briefly, receptor number was determined by incubating 1-2
X 106 T cells for 2 h at 0°C with '25I-labeled affinity-purified BSF-1/IL-4, with and
without a 200-fold excess of unlabeled lymphokine. Cells were centrifuged through silicon
oil, and cell-associated radioactivity was measured. Numbers of binding sites per cell were
calculated from Scatchard plots (20), or by using an amount of '251-BSF-1/IL-4 sufficient
to occupy >90% of available receptors.
Results
Characterization of T Cell Clones.
￿
The T cell clones used in this study are
listed in Table I. In response to stimulation by Con A or antigen and irradiated
splenocytes, all cloned lines secrete a lymphokine that stimulates DNA synthesis
by HT2 indicator cells and is identified as either IL-2 or BSF-1/IL-4 by specific
antibody inhibition (Table I). On the basis of this assay, clones D1 .1, D1 .5, D1 .6,
B8, and GI I belong to the IL-2-producing Thl subset, whereas D10.G4, CDC25,
and CDC35 are prototypical BSF-I/IL-4-producing Th2 lines. In agreement
with previous results (10), the autocrine growth factor used by each subset is also
IL-2 or BSF-1/IL-4, as determined by antibody blocking of proliferative re-
sponses to antigen plus APC (not shown).
As expected from the class II MHC restriction of these lines, all are phenotyp-
ically L3T4+, Lyt-2- and all the clones express IL-2-R (data not shown). The
level of IL-2-R expression varies among clones and in the same clone assayed at
different times. The basis for this variation is unclear, but, at least with D10.G4,
it is not attributable to the presence or absence of exogenous IL-2 (in the form
of RCS) in the culture medium during stimulation with antigen and APC.
Proliferative Responses to Exogenous Lymphokine.
￿
Viable cells from different T
cell clones were cultured with Con A, recombinant murine BSF-1/IL-4, a Con
A-induced supernatant of D10 .G4 (as a crude source of BSF-1/IL-4) or human
rIL-2, in the presence or absence of rIL-1,8 (0.5 U/ml). The pattern of prolifer-
ation detected after 2 d is strikingly different for Th l and Th2 cells. All three
Th2 clones respond to Con A, BSF-1/IL-4, and IL-2; their response to Con A
(which induces secretion of BSF-1/IL-4) and to exogenous BSF-1/IL-4 is entirely
dependent on or markedly enhanced by IL-1 (Fig. 1). These lines do proliferate
when cultured with IL-2 alone, and this is generally enhanced by IL-1 . In
contrast, the IL-2-producing Thl lines respond maximally to IL-2 but fail toKURTJONES ET AL.
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TABLE I
T Cell Clones: Specificity and Lymphokine Secretion
Antigen + Ia specificities of T cell clones used in this study were established by
inhibition of proliferative responses to antigen + APC by mAbs specific for I-Aand
I-E determinants (not shown).
To measure lymphokine secretion, SN were collectedafter 1 d culture of 2 x 10' T
cells with 2 pg/ml of Con A, or 2 d culture with 100 wg/ml antigen and 106 1,500
rad irradiated splenocytes. SN were tested at 50% vol/vol for stimulation of HT2
cellsin thepresence andabsenceofantibodies to BSF-1/IL-4or to IL-2-R, as described
in Materials and Methods. Controls included recombinant BSF-1/IL-4 (250 U/ml)
and recombinant human IL-2 (10 U/ml). Groups showing significant inhibition of
HT2 stimulation are underlined.
* Incomplete inhibition is due to thehigh concentrations of IL-2 produced.
respond to BSF-1/IL-4, and their DNA synthesis is unaffected by IL1 (Fig. 1).
The same pattern of proliferation is -observed after 5 d of culture, indicating
that the differences cannot be attributed to different response kinetics (not
shown). Similar results have been observed with four other Thl and two other
Th2 clones (data not shown).
The unresponsiveness of Thl clones to BSF-1/IL-4 and to IL-1 was investi-
gated in more detail. Over a range ofconcentrations ofrecombinant BSF-1/IL-
4 from 100-1,000 U/ml, two prototypical Th2 lines, D10.G4and CDC25, show
increasing DNA synthesis (in the presence of IL-1) with a plateau at 100-200
U/ml. Under the same conditions, three IL-2-secreting Thl clones, DIA, DI.5,
and D1.6, fail to incorporate [sH]thymidine (Fig. 2).
Both T cell subsets respond to IL-2, but-here, too, the differences in IL-1
effects are observed. Thus, DNA synthesis by Thl clones is unaffected by IL-1.
In contrast, D10.G4 and CDC25, two representative Th2 clones, clearly show
an enhancing effect ofIL-1 on IL-2-induced proliferation (Fig. 3).
Dose-response studies were also done with IL-1. As shown above (Fig. 1) and
described previously (1), DlO.G4 proliferates in response to Con A or receptor-
mediated stimulation only in the presence of IL-1. The maximal effect of IL-1
in this assay using human IL-1 is observed at a concentration of 0.1-0.5 U/ml.
Similar dose responses are seen in the stimulation of Th2 clones by BSF-1/IL-4,
i.e., maximal costimulator effects of IL-1 at 0.1-0.5 U/ml (Fig. 4). In contrast,
Thl clones do not respond to BSF-1/IL-4 even with IL-1 concentrations up to
2 U/ml (Fig. 4). At supramaximal concentrations of BSF-1/IL-4, Th2 cells
Clone Specificity
Stimulation of
(cpm/culture)
No antibody
HT2, ['H]TdR incorporation
by Tcell SN, in presence of:
Anti-BSF-
1/IL-4 Anti-IL-2-R
D10.G4 Conalbumin + I-A'` 55,619 _942 43,550
CDC25 RGG+ I-A(W)F' 65,610 3,003 43,175
CDC35 RGG+ I-Ad 42,609 5,170 30,983
B8 PPD + I-Ab 66,052 46,426 771
G11 PPD + I-Ab 101,754 101,983 31,076*
D1 .1 RGG+ I-Ad 132,006 122,375 13,764*
D1 .5 RGG+ lad 21,014 20,564 977
D1 .6 RGG+ I-Ad 24,865 16,536 329
Controls: BSF1/IL-4 25,650 653 16,722
IL-2 126,225 135,990 40917'78
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FIGURE 2. Dose response of BSF-
1/IL-4-induced stimulation of T cell
proliferation. 2 x 10' T cells were
cultured for 2 d with increasing con-
centrations of recombinant BSF-
1/IL-4, in the presence of IL-1 (0.5
U/ml).Proliferationwasmeasured as
in Fig. 1.
11L2 1 -1-1 1
￿
rIL-z ( unfiml I
FIGURE 3.
￿
Dose response of IL-2-induced stimulation of T cell proliferation. Cloned T cells
were cultured for 2 d with increasing concentrations of human HL-2, in the absence ([I) or
presence (")of IL-1,B (0.5 U/ml). Proliferation was measured as in Fig. 1.
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occasionally proliferate in the absence of exogenously added IL-1 but the
response is invariably enhanced by IL-1. Similar results have been obtained in
limited experiments with human rIL-la and with a partially purified murine
macrophage-derived IL-1 (not shown).
Influence of Culture Conditions on Lymphokine Responses.
BSF-1/IL-4 (Ohara,J., and W. E. Paul, unpublished observations) are known to
enhance expression oftheir own receptors. It is, therefore, possible that the lack
of BSF-1/IL-4 responsiveness of Thl clones is solely because the cells never
encounter this lymphokine during growth in vitro. Thus, when stimulated with
antigen and antigen-presenting cells they secrete IL-2, and the only lymphokine
added during passage in vitro is a Con A-induced RCS, which may not contain
anyBSF-1/IL-4 reactive withmurine cells.Twoapproaches weretaken toaddress
Both IL-2 (21) and1780
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TABLE II
Influence ofCulture Conditions on Lymphokine Responsiveness ofTCelts
FIGURE 4. Dose response of IL-1
effect on T cells: stimulation with
BSF-1/IL-4. 2 x 104 T cells were
cultured with 500U/ml of BSF-1/IL-
4, and increasing concentrations of
IL-I . Proliferation was measured as
in Fig. 1.
D1 .5 and D1.6 cells were cultured for 8 d with antigen + APC with and without Con A-induced
DIO.G4 SN (10% vol/vol). Viable cells were purified and tested for proliferative responses to
lymphokines, in thepresence andabsenceof IL-1 (0.5 U/ml).
this possibility. First, D1 .5 and DI.6, two IL-2-producing clones, were restim-
ulated according to the standard protocol, but Con A-induced DIO.G4 super-
natant (a rich source of BSF-1/IL-4) was added to some wells. These paired
cultures were then assayed for responses to lymphokines. As shown in Table II,
the addition ofDlO.G4 supernatant during cellpassage does notalterthe pattern
of response of two Thl clones, i.e., they remain insensitive to BSF-1/IL-4 and
to IL-1 . Moreover, the pattern of proliferation remains unchanged from 2 to 5
dofculture, although responses were considerably lower at 5 d (data not shown).
In a second set of experiments, cells of the IL-2-producing Thl clone, D1 .5,
were cultured for 3 d with rIL-2 or with recombinant BSF-1/IL-4, and then
phokine
['H]Thymidine incorporation
(mean cpm/culture)
-IL-1 +IL-1
120 144
(500) 513 327
(10) 70,606 78,890
(100) 285,053 302,743
329 104
(500) 500 570
(10) 127,943 124,699
(l00) 255,895 238,998
332 115
(500) 236 220
(10) 137,481 161,435
(100) 204,437 196,463
209 92
(500) 217 137
(10) 65,793 62,047
(100) 101,375 92,045
T cell
clone
Cultured with antigen +
APC in the presence of:
Response to l
(U/
D1 .5 RCS
BSF-1/IL-4
IL-2
DI.5 RCS+ DlO.G4 SN
BSF-1/IL-4
IL-2
D1 .6 RCS
BSF-1/IL-4
IL-2
D1 .6 RCS + DI O.G4 SN
BSF-1/IL-4
1L-2TABLE III
Lymphokine Responsiveness ofD1.5 Cells in Two-Stage Cultures
KURTJONES ET AL.
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D1 .5 cells were isolated from culture with antigen + APC, and incubated for 3 d with medium,
D10.G4 SN, BSF-1/IL-4, or IL-2. Cells were washed and 2 x 10' viable cells were stimulated with
BSF-1/IL-4 and IL-2 with and without IL-1 (0.5 U/ml). Also shown are D1 .5 and DIO.G4 cells
freshlyharvestedfrom maintenance cultures with antigen + APC andstimulated withoutpreculture.
Proliferation was measured on day2.
assayed for responses to these lymphokines in the presence and absence of IL-1.
Again, prior exposure to either lymphokine has no effect on the pattern of
response (Table III). The lower responses ofcells cultured in medium alone may
be due to decreasing viability or metabolic activity. Taken together, these
experiments demonstrate that the failure ofTh1 clones toproliferate in response
to BSF-I/IL-4 with or without IL-1 is presumably an intrinsic property ofthis T
cell subset and is not a reflection ofculture conditions.
Correlation ofBSF-1/IL-4 Responsiveness and Receptor Expression.
￿
Thesimplest
explanation for the unresponsiveness of some T cells to BSF-1/IL-4 is that they
do not express receptors for this lymphokine. We have examined BSF-1/IL-4
receptors on a representative panel of T cell clones by binding of '25I-labeled
lymphokine. In these experiments, receptor numbers on normal BALB/c spleen
cells were calculated to be 1,266 per cell with a K of 0.87 X 101° M-1 (Fig. 5).
The value for receptor number is somewhat in excess of the receptor number
observed in a previous study (450/cell) and the K was somewhat lower than the
previously measured value (3.3 X 101° M-1) (20).
Our calculation of receptor expression on Th2 clones indicates that they
express ^-2-10 times as many receptors per cell as normal splenocytes. Thl
clones generally express fewer receptors than Th2 clones, but the groups clearly
overlap in receptor expression (Table IV). The calculated Kvalues for two Th2
clones (DlO.G4 and CDC 25) and one ThI clone (G11) are also not significantly
Tcell clone First culture Second culture: lym-
phokine (U/ml)
['H]Thymidine incorpora-
tion (meancpm/culture)
-IL-1 +IL-1
D1 .5 Medium - 527 178
BSF-1/IL-4 (500) 135 336
IL-2 (100) 12,109 12,658
D1 .5 DIO.G4 SN 10% - 170 168
BSF-1/IL-4 (500) 246 266
IL-2 (100) 36,718 35,834
D1 .5 BSF1/IL4 500 U/ml - 171 313
BSF-1/1L-4 (500) 135 264
IL-2 (100) 24,556 19,164
131.5 IL2 50 U/ml - 493 463
BSF-1/IL-4 (500) 750 486
IL-2 (100) 40,042 36,291
131.5 None - 324 354
BSF-1/IL-4 (500) 573 616
IL-2 (100) 90,389 89,523
DIO.G4 None - 582 3,196
BSF-1/IL-4 (500) 3,100 34,193
IL-2 (100) 64,159 125,5491782
m
0.8
0.6
0.4
0.2
0.0
BSF-1/IL-4-RExpression on Cloned T Cells
DIO.G4 cells
cultured in
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FIGURE 5.
￿
Bindingof 1211-IL-4 to spleen cells. Puri-
fied T cell-derived BSF-1/IL-4 wasradioiodinated as
described (20). Specific activiwas determined by a
competition assay in which '%I-IL-4 was compared
with known quantities of nonradioactive IL-4 (20).
60% of the '2 I-IL-4 preparation used in these exper-
iments was capable ofbinding to spleen cells. Binding
data were correctedforthis factor. The specific activ-
ity of this preparation at the time of initial assay was
1 .70 x 10-" mol IL-4 per cpm. All binding experi-
ments were carried outat 4°C for 2 h, conditions that
achieve equilibrium. In theexperiment illustrated, cell
density was 3.98 X 106 cells in 0.1 ml.
TABLE IV
TABLE V
BALB/c spleen receptor is derived from data in Fig. 5. The results for
Thl and Th2 cloned T cell lines were obtained in thesame experiment.
Receptor numbers for D10.G4, CDC25, and G11 cells are based on
Scatchardanalysis. For other cell types, single pointdeterminations were
carried outat near saturation conditions.
IL-1 Does NotIncrease Expression ofIL-4-R on D10.G4 Cells
Receptors/cell
Exp. 1
￿
Exp. 2
Medium
￿
3,080
￿
4,110
IL-1
￿
3,210
￿
2,810
D10.G4 cells were cultured for IS h in medium alone or with IL-1 (1
U/ml). IL-4-R were measured in triplicate, as described. Receptor number
was calculated from a single point measurement under near saturation
conditions.
different from normal splenocytes. Moreover, BSF-1/IL-4-R density on D10.G4
cells is unaffected by culture with IL-1 (Table V). Therefore, it is unlikely that
IL-1 functions simply by inducing or stimulating the expression ofreceptors for
this autocrine growth-promoting lymphokine.
Specificity of Lymphokine-mediated Stimulation.
￿
To confirm the specificity of
lymphokine-mediated stimulation, we cultured a Th2 clone that responds to
both IL-2 and BSF-1/IL-4 (+IL-1), D10.G4, with these lymphokines in the
presence and absence of neutralizing mAbs specific for IL-2 or BSF-1/IL-4. As
Cells Type IL-4-R percell
BALB/c spleen Normal spleen 1,266
DIO.G4 Th2 10,900
CDC25 Th2 2,400
CD35 Th2 5,200
D1 .1 Th I 540
D1 .6 Thl 3,300
B8 Th l 1,600
G11 Thl 2,200KURTJONES ET AL.
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TABLE VI
Specificity ofLymphokine-induced Stimulation ofD10.G4
2 x 10' D10.G4 cells were cultured for 2 d as shown, with no antibody, anti-
BSF-1/IL-4 (I IB11 hybridoma SN, 1:40), or anti-IL-2 (S4B6, 1:20). The IL-2
used in this experiment was recombinant murine IL-2. Proliferation was meas-
ured on day 2. Groups showingsignificant inhibition areunderlined.
shown in Table VI, the proliferation ofD10.G4 induced by each lymphokine is
significantly inhibited only by the specific antibody. In addition to demonstrating
specificity, this result indicates that the major portion of the response to an
exogenous lymphokine is due to the direct action of that lymphokine, and not
due to secondary stimulation of autocrine growth factor production. In other
words, IL-2 stimulates D10.G4 directly and not by inducing the secretion of
BSF-1/IL-4.
Discussion
The experiments described in thispaper were initiated after the discovery that
subsets of helper/inducer T lymphocytes can be distinguished by profiles of
lymphokine secretion and autocrine growth factor utilization (9-11). Such dif-
ferences may provide the biologically most meaningful criteria for distinguishing
the functional potential of T cell subsets. The results described above establish
two striking differences between these subsets. First, both IL-2- and BSF-1/IL-
4-producing (Thl and Th2) clones proliferate in response to exogenous IL-2,
but only the Th2 clones respond toBSF-1/IL-4. Second, responses ofTh2 clones
are dependent on or enhanced by the accessory cell-derived costimulator, IL-1,
but Thl cells are IL-1-insensitive.
The nonreciprocal pattern ofproliferative responses of Thl and Th2 subsets
to exogenous lymphokines is not attributable to culture conditions or to prior
exposure to these lymphokines. We also believe that unresponsiveness of Thl
cells to BSF-1/IL-4 is not due to a failure to identify a costimulator that must act
in concert with this lymphokine, for two reasons: (a) no such costimulator (other
than IL-I) is necessary for clones that are responsive to BSF-1/IL-4, and (b) such
an accessory function is not provided by PMA, which is the most efficient
costimulator (and the only one other than IL-1) that has been shown to act on T
cells (data not shown). Initial studies suggest that most Th1 clones express lower
levels of BSF-1/IL-4-R than Th2 clones, but there is overlap among the cell
lines, suggesting that the failure of the Thl cells to respond to this lymphokine
may not be solely related to receptor expression, but may reflect other events in
the activation pathway. Moreover, recent experiments suggest that Thl clones
['H]Thymidine incorporation
Stimuli (U/ml)
(mean
No anti-
body
cpm/culture)
Anti-BSF-
1/IL-4
with:
Anti-IL-2
- 333 ND ND
IL-1 (0.1) 3,515 ND ND
BSF-1/IL-4 (500) + IL-1 (0.1) 22,361 1,370 26,632
IL-2 (50) + IL-1 (0.1) 25,102 15,949 3,942
D10.G4SN (25%)+ IL-1 (0.1) 56,365 4,347 56,3151784
￿
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may respond to BSF-1/IL-4 for short periods (up to 3-4 d) after receptor-
mediated stimulation, but rapidly lose this responsiveness, whereas Th2 clones
continue to proliferate in response to IL-4 (+ IL-1) for at least 2 wk after
antigenic stimulation.
The differences in the IL-1 sensitivity of T cell subsets described in this report
might account for the fact that in various studies using bulk populations of T
cells, proliferative responses have been shown to be either dependent on or
unaffected by IL-I . Thus, in many instances the proliferation of naive T cells
induced by alloantigens of mitogenic lectins requires accessory cells whose
function cannot be replaced by IL-1 (6-8). On the basis of our results, we would
predict that these responding T cells belong to the IL-2-producing Thl subset.
In fact, recent experiments have shown that naive murine lymph node T cells
stimulated by Con A or alloantigen secrete IL-2 and no BSF-1/IL-4, and the IL-
4-secreting subset appears in immunized, antigen-responsive populations, at least
within the limits of sensitivity of the assays we have used (Powers, G. D., A. K.
Abbas, and R. A. Miller, manuscript in preparation). In contrast to the frequent
findings with naive T cells, a critical role for IL-1 in T cell proliferation has been
most often observed with cloned lines such as D10.G4 and CDC25 (1, 22, 23),
which are now known to belong to the Th2 subset, or with antigen-primed and
restimulated bulk populations (24-26), which we have found to contain a
significant proportion of BSF-1/IL-4-secreting cells by limiting dilution analysis
(Powers, G. D., et al.. manuscript in preparation). The mechanism by which IL-
I functions as a costimulator for T cell proliferation is not known. With the
cloned lines used in this study, IL-1 has no effect on lymphokine secretion
(reference 27 and data not shown) or lymphokine receptor expression. Experi-
ments are in progress to determine if sensitivity to IL-1 is related to the expression
of high-affinity IL-1-R.
Based on the results reported above and described previously (10), we can
summarize the responses of clones representing Thl and Th2 subsets of
helper/inducer T cells as follows . When stimulated via their antigen receptors,
IL-2-producing Thl cells secrete IL-2 and express receptors for IL-2, and this
autocrine pathway is sufficient to induce proliferation. Such cells may express
lower levels of receptors for BSF-1/IL-4, and because of this or other reasons
they fail to respond to BSF-1/IL-4, regardless of what costimulator or accessory
factor is present. Th2 cells also secrete their lymphokines after receptor-mediated
stimulation, but their response to the autocrine growth factor requires a co-
stimulator activity that is provided by IL-1 . The Th2 cells respond to IL-2, which
they themselves do not secrete. Thus, IL-2 produced by Thl cells is capable of
inducing proliferation of adjacent T cells, but BSF-1/IL-4 secretion by Th2 cells
will only affect other cells belonging to the same subset. It is, therefore, reason-
able to predict that production of IL-2, but not BSF-1/IL-4, may play a role in
antigen-independent expansion of "bystander" T cells.
Finally, we do not know to what extent our results with cloned lines are
applicable to other helper/inducer clones and unselected, bulk T cell populations.
The majority of nonimmune T lymphocytes proliferate in response to exogenous
IL-2 (28). This is not surprising given our finding that both Thl and Th2 cells
are responsive to this lymphokine. Recent experiments indicate that restingKURTJONES ET AL.
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peripheral T cells also proliferate in response to BSF-1/IL-4 + PMA (5). The
difference between such cells (most of which are IL-2 producers) and established
cloned lines is a question that remains to be answered.
Summary
Antigen-specific, la-restricted helper/inducer T lymphocytes consist of subsets
that can be distinguished by lymphokine secretion. One, called Th1, secretes IL-
2 and the other, termed Th2, produces BSF-1/IL-4 in response to stimulation
by lectin or antigen receptor signals, and each uses the respective lymphokine as
its autocrine growth factor. Cloned lines representing Th2 cells proliferate in
response to both IL-2 and their autocrine lymphokine, BSF-I/IL-4, but this
proliferation is dependent on the synergistic costimulator activity of the mon-
okine, IL-1 . In contrast, Thl clones proliferate only in response to IL-2, are
unresponsive to BSF-1/IL-4, and their growth is unaffected by IL-1 . These
response patterns are not attributable to variations in culture conditions but
apparently reflect intrinsic properties of the two T cell subsets. Moreover, the
unresponsiveness of Thl cells to BSF-I/IL-4 may be related to lower levels of
expression of surface receptors for this lymphokine. These results may explain
the observed heterogeneity among bulk populations of T cells in terms of
lymphokine responsiveness andrequirementfor accessoryfactors(costimulators).
In addition, our findings suggest that IL-2, unlike BSF-1/IL-4, is a fully compe-
tent growth factor that is potentially involved in antigen-independent expansion
of bystander T cells present at sites of immune stimulation.
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Note added in proof. Recent experiments have shown that Th2 clones express high-affinity IL-1
receptors, whereasThI clones that are insensitive to IL-1 do not express high-affinity receptors for
IL-1 (Lichtman, A. H., J. A. Schmidt, and A. K. Abbas, manuscript in preparation).
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